{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:52:52Z","timestamp":1754488372684},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T00:00:00Z","timestamp":1392422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11033-014-3231-5","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T15:19:25Z","timestamp":1392650365000},"page":"3671-3676","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G\/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey"],"prefix":"10.1007","volume":"41","author":[{"given":"Serdar","family":"Oztuzcu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sercan","family":"Ergun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ula\u015fl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclper","family":"Nacarkahya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf Ziya","family":"I\u011fci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehri","family":"I\u011fci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recep","family":"Bayraktar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Tamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ecir Ali","family":"\u00c7akmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,15]]},"reference":[{"issue":"4","key":"3231_CR1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.59566\/IJBS.2011.7238","volume":"7","author":"SA Sheweita","year":"2011","unstructured":"Sheweita SA, Baghdadi H, Allam AR (2011) Role of genetic changes in the progression of cardiovascular diseases. Int J Biomed Sci 7(4):238\u2013248","journal-title":"Int J Biomed Sci"},{"issue":"2","key":"3231_CR2","first-page":"89","volume":"13","author":"R Torabi","year":"2012","unstructured":"Torabi R, Zarei S, Zeraati H, Zarnani AH, Akhondi MM, Hadavi R, Shiraz ES, Jeddi-Tehrani M (2012) Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss. J Reprod Infertil 13(2):89\u201394","journal-title":"J Reprod Infertil"},{"issue":"1","key":"3231_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2169\/internalmedicine.50.4144","volume":"50","author":"E Tug","year":"2011","unstructured":"Tug E, Aydin H, Kaplan E, Dogruer D (2011) Frequency of genetic mutations associated with thromboembolism in the Western Black Sea Region. Intern Med 50(1):17\u201321","journal-title":"Intern Med"},{"issue":"16","key":"3231_CR4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1997.03540400055031","volume":"277","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997) Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. JAMA 277(16):1305\u20131307","journal-title":"JAMA"},{"issue":"3","key":"3231_CR5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J","volume":"73","author":"JP Gregg","year":"1997","unstructured":"Gregg JP, Yamane AJ, Grody WW (1997) Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. Am J Med Genet 73(3):334\u2013336","journal-title":"Am J Med Genet"},{"issue":"4","key":"3231_CR6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-996025","volume":"24","author":"V Stefano De","year":"1998","unstructured":"De Stefano V, Chiusolo P, Paciaroni K, Leone G (1998) Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 24(4):367\u2013379","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"3231_CR7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","volume":"79","author":"FR Rosendaal","year":"1998","unstructured":"Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79(4):706\u2013708","journal-title":"Thromb Haemost"},{"issue":"2","key":"3231_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2141.1997.2353052.x","volume":"98","author":"AM Cumming","year":"1997","unstructured":"Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR (1997) The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population. Br J Haematol 98(2):353\u2013355","journal-title":"Br J Haematol"},{"issue":"27","key":"3231_CR9","doi-asserted-by":"crossref","first-page":"20627","DOI":"10.1074\/jbc.M000209200","volume":"275","author":"TA Trumbo","year":"2000","unstructured":"Trumbo TA, Maurer MC (2000) Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the\u00a0factor XIII V34L mutation. J Biol Chem 275(27):20627\u201320631","journal-title":"J Biol Chem"},{"issue":"1","key":"3231_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1538-7836.2006.02182.x","volume":"5","author":"L Muszbek","year":"2007","unstructured":"Muszbek L, Ari\u00ebns RA, Ichinose A (2007) Factor XIII: recommended terms and abbreviations. J Thromb Haemost 5(1):181\u2013183","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3231_CR11","first-page":"551","volume":"7","author":"P Goyette","year":"1994","unstructured":"Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 7(4):551","journal-title":"Nat Genet"},{"issue":"3","key":"3231_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<280::AID-HUMU9>3.0.CO;2-I","volume":"15","author":"S Sibani","year":"2000","unstructured":"Sibani S, Christensen B, O\u2019Ferrall E, Saadi I, Hiou-Tim F, Rosenblatt DS, Rozen R (2000) Characterization of six novel mutations in the methylenetetrahydrofolate reductase (MTHFR) gene in patients with homocystinuria. Hum Mutat 15(3):280\u2013287","journal-title":"Hum Mutat"},{"issue":"5","key":"3231_CR13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/301825","volume":"62","author":"NM Put van der","year":"1998","unstructured":"van der Put NM, Gabre\u00ebls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 62(5):1044\u20131051","journal-title":"Am J Hum Genet"},{"issue":"2","key":"3231_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10192","volume":"71","author":"G Balta","year":"2002","unstructured":"Balta G, Altay C, Gurgey A (2002) PAI-1 gene 4G\/5G genotype: a risk factor for thrombosis in vessels of internal organs. Am J Hematol 71(2):89\u201393","journal-title":"Am J Hematol"},{"issue":"3","key":"3231_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10741-011-9257-z","volume":"17","author":"I Falc\u00e3o-Pires","year":"2012","unstructured":"Falc\u00e3o-Pires I, Leite-Moreira AF (2012) Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev 17(3):325\u2013344","journal-title":"Heart Fail Rev"},{"issue":"12","key":"3231_CR16","first-page":"532","volume":"9","author":"MA Ajabnoor","year":"2003","unstructured":"Ajabnoor MA, AL-Ama MN, Banjar Z, Rafee AA, Sheweita SA (2003) Homocysteine level and other biochemical parameters in cardiovascular disease patients with diabetes mellitus. Med Sci Monit 9(12):7\u2013532","journal-title":"Med Sci Monit"},{"issue":"4","key":"3231_CR17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1194\/jlr.M012963","volume":"52","author":"Q Chen","year":"2011","unstructured":"Chen Q, Reis SE, Kammerer C, Craig W, McNamara DM, Holubkov R, Sharaf BL, Sopko G, Pauly DF, Merz CN, Kamboh MI (2011) Association of antioxidized LDL and candidate genes with severity of coronary stenosis in the Women\u2019s Ischemia Syndrome Evaluation study. J Lipid Res 52(4):801\u2013807","journal-title":"J Lipid Res"},{"issue":"Suppl 2","key":"3231_CR18","first-page":"1","volume":"30","author":"PH Reitsma","year":"2000","unstructured":"Reitsma PH (2000) Genetic heterogeneity in hereditary thrombophilia. Haemostasis 30(Suppl 2):1\u201310","journal-title":"Haemostasis"},{"issue":"10","key":"3231_CR19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00277-007-0327-1","volume":"86","author":"A Altintas","year":"2007","unstructured":"Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, Batun S, Isi H (2007) Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol 86(10):727\u2013731","journal-title":"Ann Hematol"},{"issue":"15","key":"3231_CR20","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2174\/092986708784638852","volume":"15","author":"PG Lindqvist","year":"2008","unstructured":"Lindqvist PG, Dahlback B (2008) Carriership of factor V Leiden and evolutionary selection advantage. Curr Med Chem 15(15):1541\u20131544","journal-title":"Curr Med Chem"},{"issue":"1","key":"3231_CR21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2008-01-077909","volume":"112","author":"B Dahlback","year":"2008","unstructured":"Dahlback B (2008) Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112(1):19\u201327","journal-title":"Blood"},{"issue":"6","key":"3231_CR22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1055\/s-0038-1665446","volume":"78","author":"N Akar","year":"1997","unstructured":"Akar N, Akar E, Dalg\u0131n G, Sozuoz A, Omurlu K, Cin S (1997) Frequency of Factor V (1691 G-A) mutation in Turkish population. Thromb Haemost 78(6):1527\u20131528","journal-title":"Thromb Haemost"},{"issue":"21","key":"3231_CR23","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1182\/blood-2009-02-203281","volume":"113","author":"M Makris","year":"2009","unstructured":"Makris M (2009) Thrombophilia: grading the risk. Blood 113(21):5038\u20135039","journal-title":"Blood"},{"issue":"1","key":"3231_CR24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12031-011-9580-9","volume":"46","author":"TP They-They","year":"2012","unstructured":"They-They TP, Battas O, Slassi I, Rafai MA (2012) KatumbayDT, Nadifi S. Prothrombin G20210A and factor V Leiden polymorphisms in stroke. J Mol Neurosci 46(1):210\u2013216","journal-title":"J Mol Neurosci"},{"issue":"4","key":"3231_CR25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","volume":"79","author":"FR Rosendaal","year":"1998","unstructured":"Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79(4):706\u2013708","journal-title":"Thromb Haemost"},{"issue":"6","key":"3231_CR26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4065\/75.6.595","volume":"75","author":"A Nguyen","year":"2000","unstructured":"Nguyen A (2000) Prothrombin G20210A polymorphism and thrombophilia. Mayo Clin Proc 75(6):595\u2013604","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"3231_CR27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00439-003-1040-3","volume":"114","author":"CK Heng","year":"2004","unstructured":"Heng CK, Lal S, Saha N, Low PS, Kamboh MI (2004) The impact of\u00a0factor\u00a0XIIIa\u00a0V34L\u00a0polymorphism on plasma\u00a0factor XIII\u00a0activity in the Chinese and Asian Indians from Singapore. Hum Genet 114(2):186\u2013191","journal-title":"Hum Genet"},{"issue":"3","key":"3231_CR28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11033-007-9096-0","volume":"35","author":"RA Mahfouz","year":"2008","unstructured":"Mahfouz RA, Sabbagh AS, Shammaa DM, Otrock ZK, Zaatari GS, Taher AT (2008) Factor XIII gene V34L mutation in the Lebanese population: another unique feature in this community? Mol Biol Rep 35(3):375\u2013378","journal-title":"Mol Biol Rep"},{"key":"3231_CR29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0083-6729(08)00413-5","volume":"79","author":"P Thomas","year":"2008","unstructured":"Thomas P, Fenech M (2008) Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitam Horm 79:375\u2013392","journal-title":"Vitam Horm"},{"issue":"9","key":"3231_CR30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.ejhg.5200522","volume":"8","author":"A Homberger","year":"2000","unstructured":"Homberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E, Koch HG (2000) Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J Hum Genet 8(9):725\u2013729","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"3231_CR31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/(SICI)1096-8628(19991008)86:4<380::AID-AJMG13>3.0.CO;2-9","volume":"86","author":"PL Rady","year":"1999","unstructured":"Rady PL, Tyring SK, Hudnall SD, Vargas T, Kellner LH, Nitowsky H, Matalon RK (1999) Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 86(4):380\u2013384","journal-title":"Am J Med Genet"},{"issue":"1","key":"3231_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111\u2013113","journal-title":"Nat Genet"},{"issue":"1","key":"3231_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cbf.1132","volume":"23","author":"A Sazci","year":"2005","unstructured":"Sazci A, Ergul E, Kaya G, Kara I (2005) Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct 23(1):51\u201354","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"3231_CR34","first-page":"113","volume":"15","author":"F Ozmen","year":"2009","unstructured":"Ozmen F, Ozmen MM, Ozalp N, Akar N (2009) The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ulus Travma Acil Cerrahi Derg 15(2):113\u2013119","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"issue":"2","key":"3231_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0897.2006.00454.x","volume":"57","author":"A Sotiriadis","year":"2007","unstructured":"Sotiriadis A, Vartholomatos G, Pavlou M, Kolaitis N, Dova L, Stefos T, Paraskevaidis E, Kalantaridou SN (2007) Combined thrombophilic mutations in women with unexplained recurrent miscarriage. Am J Reprod Immunol 57(2):133\u2013141","journal-title":"Am J Reprod Immunol"},{"issue":"7","key":"3231_CR36","first-page":"1249","volume":"125","author":"KN Kim","year":"2012","unstructured":"Kim KN, Kim KM, Kim BT, Joo NS, Cho DY, Lee DJ (2012) Relationship of plasminogen activator inhibitor 1 gene 4G\/5G polymorphisms to hypertension in Korean women. Chin Med J (Engl) 125(7):1249\u20131253","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"3231_CR37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1373\/49.7.1081","volume":"49","author":"A Dossenbach-Glaninger","year":"2003","unstructured":"Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, Huber J, Hopmeier P (2003) Plasminogen activator inhibitor 1 4G\/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 49(7):1081\u20131086","journal-title":"Clin Chem"},{"issue":"1","key":"3231_CR38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.CIR.101.1.67","volume":"101","author":"M Roest","year":"2000","unstructured":"Roest M, van der Schouw YT, Banga JD, Tempelman MJ, de Groot PG, Sixma JJ, Grobbee DE (2000) Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 101(1):67\u201370","journal-title":"Circulation"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3231-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-014-3231-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3231-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T09:00:29Z","timestamp":1716541229000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-014-3231-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,15]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["3231"],"URL":"https:\/\/doi.org\/10.1007\/s11033-014-3231-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,15]]}}}